- Report
- October 2024
- 185 Pages
Global
From €3389EUR$3,545USD£2,837GBP
€3766EUR$3,939USD£3,152GBP
- Report
- October 2024
- 175 Pages
Global
From €4780EUR$5,000USD£4,002GBP
- Report
- February 2025
- 150 Pages
Global
From €4637EUR$4,850USD£3,882GBP
- Report
- December 2023
- 160 Pages
Global
From €2390EUR$2,500USD£2,001GBP
- Report
- January 2024
- 112 Pages
Global
From €3500EUR$3,921USD£3,032GBP
- Report
- October 2024
Global
From €3346EUR$3,500USD£2,801GBP
- Report
- October 2024
Global
From €3346EUR$3,500USD£2,801GBP
- Report
- October 2024
Global
From €3346EUR$3,500USD£2,801GBP
- Report
- June 2024
Global
From €813EUR$850USD£680GBP
The Bilirubin Test is a type of In Vitro Diagnostics (IVD) used to measure the amount of bilirubin in a patient's blood. Bilirubin is a yellow pigment produced by the breakdown of red blood cells. High levels of bilirubin can indicate liver or gallbladder disease, or other conditions such as anemia. The Bilirubin Test market is composed of a variety of products, including reagents, instruments, and software. Reagents are used to measure bilirubin levels in a patient's blood, while instruments are used to analyze the results. Software is used to store and analyze the data.
The Bilirubin Test market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, Ortho Clinical Diagnostics, and Beckman Coulter. Show Less Read more